Clinical trial
SPP100 Dose Finding Study in Japan
NCT00311012 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00311012 |
|---|---|
| Title | SPP100 Dose Finding Study in Japan |
| Official title | Dose-finding Study of SPP100 in Essential Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Aliskiren |
| Enrollment | 445 |
| Start date | Aug 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Apr 5, 2006 |
| Last update posted | Nov 8, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: